What is the prognosis of mantle cell lymphoma?
Mantle cell lymphoma (MCL) is a type of non-Hodgkin’s lymphoma, comprising about 6% of non-Hodgkin’s lymphoma cases.
Symptoms of mantle cell lymphoma are similar to those of other types of lymphoma, which include: skin reactions, temporary hair loss, infections, nausea and diarrhea, persistent fatigue, shortness of breath and so on.
In terms of its prognosis, MCL has a poor prognosis, even with appropriate therapy.
Less than 18 months, treatment failures will be noted, the average survival time for people with MCL is about 2 to 5 years.
The ten-year survival rate is only about 5%-10%. But if treated with intensive regimen of chemotherapy, the average survival rate may rise.
Keywords: mantle cell lymphoma; mantle cell lymphoma+; mantle cell lymphoma prognosis; mantle lymphoma prognosis